European developments surrounding the patentability of plants and animals have become rather political, but there are ways for patentees to mitigate the effects of political influence over the patenting process, writes Jane Wainwright of Potter Clarkson.
Latest europe news
Merck will divest its biosimilars business to Fresenius Kabi in order to focus on innovative drugs.
- Video: Osborne Clarke on Arrow declarations 30-03-2017
- EPO to grant UC, Berkeley CRISPR patent 28-03-2017